Advertisement
Advertisement

CRBP

CRBP logo

Corbus Pharmaceuticals Holdings, Inc.

8.18
USD
Sponsored
-0.29
-3.37%
Jun 24, 16:00 UTC -4
Closed
exchange

Pre-Market

8.23

+0.06
+0.73%

CRBP Earnings Reports

Positive Surprise Ratio

CRBP beat 23 of 42 last estimates.

55%

Next Report

Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$1.28
Implied change from Q1 26 (Revenue/ EPS)
--
/
+4.07%
Implied change from Q2 25 (Revenue/ EPS)
--
/
-11.11%

Corbus Pharmaceuticals Holdings, Inc. earnings per share and revenue

On May 12, 2026, CRBP reported earnings of -1.23 USD per share (EPS) for Q1 26, beating the estimate of -1.24 USD, resulting in a 1.16% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +3.53% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 7 analysts forecast an EPS of -1.28 USD, with revenue projected to reach -- USD, implying an increase of 4.07% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q1 2026, Corbus Pharmaceuticals Holdings, Inc. reported EPS of -$1.23, beating estimates by 1.16%, and revenue of $0.00, 0% as expectations.
The stock price moved up 3.53%, changed from $11.04 before the earnings release to $11.43 the day after.
The next earning report is scheduled for Aug 03, 2026.
Based on 7 analysts, Corbus Pharmaceuticals Holdings, Inc. is expected to report EPS of -$1.28 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement